Abstract
The role of functional polymorphism within IL10 (rs1800896) in colorectal cancer (CRC) still remains elusive. The aim of present study was to investigate the significance of -1082A/G polymorphism in IL10 on CRC risk, progression, and overall survival in a cohort of Bulgarian patients. Also, a functional role of this polymorphism on systemic and local level of IL10 mRNA quantity and serum IL-10 level was explored. A group of 119 patients with sporadic CRC and 154 age-sex-matched controls were genotyped by allele-specific PCR. The quantification of mRNA and serum IL-10 levels was performed by real-time PCR and ELISA assays, respectively. The genotype and allelic frequency among cases and controls was similar. However, we observed significant elevation of G-allele and GG-genotype frequencies among advanced CRC. G-allele was overrepresented in advanced CRC patients (49 %) compared to early CRC (35 %) with OR = 1.77; 95%CI 1.018 ÷ 3.083; P = 0.031. A significant upregulated expression of IL10 mRNA was observed among AG/GG-genotypes in tumor tissue compared to homozygous AA-genotype (RQ value 68.3 vs. 6.68; P = 0.0062). Also, GG-genotype of -1082A/G polymorphism in IL10 was positively associated with higher serum IL-10 among early CRC patients and controls, in contrast to advanced cases. Although, investigated polymorphism in IL10 has no significant impact of overall survival among Bulgarian CRC patients, we found a significant relationship of high pre-operative serum level of IL-10 with poor survival of CRC (P = 0.023). Our findings indicate a significant impact of -1082A/G polymorphism of IL10 on CRC progression, rather than genetic predisposition and prognosis of CRC.
MeSH Terms
Aged
Aged, 80 and over
Alleles
Case-Control Studies
Colorectal Neoplasms/blood,genetics,mortality,pathology
Disease Progression
Gene Expression
Gene Frequency
Genotype
Humans
Interleukin-10/blood,genetics
Middle Aged
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Staging
Odds Ratio
Polymorphism, Single Nucleotide
Prognosis
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Miteva Lyuba D
Department of Molecular Biology, Immunology and Medical Genetics, Medical Faculty, Trakia University, Armeiska 11 St., 6000, Stara Zagora, Bulgaria.
Stanilov Noyko S
Deliysky Tashko S
Stanilova Spaska A
References (26)
26 references, click to expand
-
Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
Carcinogenesis. 2008 Aug;29(8):1572-80
PMID: 18628251
-
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
Cancer. 1999 Nov 15;86(10):1936-43
PMID: 10570416
-
Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.
Crit Rev Immunol. 2012;32(1):23-63
PMID: 22428854
-
Immune microenvironments in solid tumors: new targets for therapy.
Genes Dev. 2011 Dec 15;25(24):2559-72
PMID: 22190457
-
Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
Anticancer Res. 2009 Dec;29(12):5005-12
PMID: 20044609
-
Regulatory lymphocytes and intestinal inflammation.
Annu Rev Immunol. 2009;27:313-38
PMID: 19302043
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods. 2001 Dec;25(4):402-8
PMID: 11846609
-
Cytokine promoter polymorphisms and risk of colorectal cancer.
Clin Lab. 2013;59(7-8):773-9
PMID: 24133905
-
Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
Ann N Y Acad Sci. 2006 Nov;1089:98-103
PMID: 17261758
-
Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.
Intensive Care Med. 2006 Feb;32(2):260-266
PMID: 16435103
-
The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival.
Br J Cancer. 2006 May 22;94(10):1412-9
PMID: 16641913
-
Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.
Genet Mol Res. 2012 Sep 25;11(3):3389-97
PMID: 23079832
-
Interleukin-10 and the immune response against cancer: a counterpoint.
J Leukoc Biol. 2005 Nov;78(5):1043-51
PMID: 16204623
-
Sp1 binds to the G allele of the-1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production.
Genes Immun. 2010 Mar;11(2):181-7
PMID: 20072143
-
Interleukin-10: new perspectives on an old cytokine.
Immunol Rev. 2008 Dec;226:205-18
PMID: 19161426
-
Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer.
Clin Colorectal Cancer. 2008 Sep;7(5):331-7
PMID: 18794066
-
An investigation of polymorphism in the interleukin-10 gene promoter.
Eur J Immunogenet. 1997 Feb;24(1):1-8
PMID: 9043871
-
Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Carcinogenesis. 2008 Jun;29(6):1202-6
PMID: 18448485
-
Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.
Cancer Causes Control. 2009 Nov;20(9):1739-51
PMID: 19760027
-
Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.
Comp Med. 2008 Dec;58(6):534-41
PMID: 19149410
-
What are regulatory T cells (Treg) regulating in cancer and why?
Semin Cancer Biol. 2012 Aug;22(4):327-34
PMID: 22465232
-
Mapping of the human IL10 gene and further characterization of the 5' flanking sequence.
Immunogenetics. 1997;46(2):120-8
PMID: 9162098
-
Interleukin-10 and the interleukin-10 receptor.
Annu Rev Immunol. 2001;19:683-765
PMID: 11244051
-
Cytokines and Immune Response in the Tumor Microenvironment.
J Immunother (1991). 2001 Sep-Oct;24(5):392-407
PMID: 11685082
-
The combined effect of interleukin (IL)-10 and IL-12 polymorphisms on induced cytokine production.
Hum Immunol. 2008 Sep;69(9):562-6
PMID: 18703108
-
Inflammation and colon cancer.
Gastroenterology. 2010 Jun;138(6):2101-2114.e5
PMID: 20420949